PFT-X-beta

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NamePFT-X-beta
Drug Alias Namesecond generation pifithrin-beta (Quark)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor protein p53 inhibitors
TargetsTumor protein p53
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuark Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuark Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A